Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$196.93 0.0%	$181.98	$141.74 ▼ $263.24	$14.28B	1.63	916,097 shs	712,803 shs
DXCM DexCom	$82.73 -1.0%	$83.03	$57.52 ▼ $117.19	$32.44B	1.44	4.40 million shs	1.84 million shs
HQY HealthEquity	$99.55 -1.7%	$99.47	$65.01 ▼ $116.65	$8.61B	0.49	861,393 shs	627,812 shs
HSIC Henry Schein	$74.67 +0.2%	$70.51	$60.56 ▼ $82.49	$9.09B	0.87	1.72 million shs	699,008 shs

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	-0.03%	+4.89%	+9.92%	+28.28%	-19.08%
DXCM DexCom	-1.02%	-2.72%	-4.68%	+38.28%	-25.41%
HQY HealthEquity	-1.71%	-5.06%	-4.06%	+26.33%	+19.14%
HSIC Henry Schein	+0.25%	+2.07%	+5.80%	+14.04%	+15.24%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.5466 of 5 stars	3.3	4.0	3.8	2.9	1.7	1.3
DXCM DexCom	4.8964 of 5 stars	3.5	5.0	4.7	2.8	2.5	1.9
HQY HealthEquity	3.7453 of 5 stars	3.5	3.0	0.0	2.7	2.5	1.9
HSIC Henry Schein	3.0965 of 5 stars	1.3	1.0	3.4	2.9	1.7	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.67	Moderate Buy	$241.25	22.51% Upside
DXCM DexCom	2.95	Moderate Buy	$98.50	19.06% Upside
HQY HealthEquity	3.00	Buy	$118.09	18.62% Upside
HSIC Henry Schein	2.64	Moderate Buy	$79.30	6.21% Upside

Current Analyst Ratings Breakdown

Latest ALGN, DXCM, HQY, and HSIC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	DXCM DexCom	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$102.00
6/5/2025	HQY HealthEquity	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $125.00
6/5/2025	HQY HealthEquity	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$98.00 ➝ $115.00
6/4/2025	HQY HealthEquity	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$94.00 ➝ $104.00
6/4/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$112.00 ➝ $117.00
6/4/2025	HQY HealthEquity	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Market Outperform ➝ Market Outperform	$110.00 ➝ $117.00
6/4/2025	HQY HealthEquity	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$110.00 ➝ $125.00
5/30/2025	DXCM DexCom	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$104.00
5/22/2025	DXCM DexCom	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$82.00 ➝ $102.00
5/22/2025	HQY HealthEquity	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$105.00 ➝ $112.00
5/6/2025	HSIC Henry Schein	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$80.00 ➝ $75.00

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$4.00B	3.57	$8.98 per share	21.92	$51.60 per share	3.82
DXCM DexCom	$4.15B	7.82	$2.22 per share	37.19	$5.38 per share	15.38
HQY HealthEquity	$1.20B	7.17	$4.19 per share	23.76	$24.56 per share	4.05
HSIC Henry Schein	$12.67B	0.72	$7.35 per share	10.16	$32.33 per share	2.31

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.49	35.87	22.00	2.09	10.29%	13.52%	8.36%	7/30/2025 (Confirmed)
DXCM DexCom	$576.20M	$1.34	61.74	33.63	1.78	12.90%	30.05%	10.00%	7/24/2025 (Estimated)
HQY HealthEquity	$96.70M	$1.37	72.66	35.05	1.56	9.80%	11.01%	6.77%	9/2/2025 (Estimated)
HSIC Henry Schein	$390M	$3.20	23.33	14.87	2.40	3.21%	14.87%	5.82%	8/5/2025 (Estimated)

Latest ALGN, DXCM, HQY, and HSIC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	ALGN Align Technology	$2.57	N/A	N/A	N/A	$1.06 billion	N/A
7/24/2025	Q2 2025	DXCM DexCom	$0.45	N/A	N/A	N/A	$1.13 billion	N/A
6/3/2025	Q1 2026	HQY HealthEquity	$0.81	$0.97	+$0.16	$0.61	$322.25 million	$330.80 million
5/5/2025	Q1 2025	HSIC Henry Schein	$1.11	$1.15	+$0.04	$0.88	$3.24 billion	$3.17 billion
5/1/2025	Q1 2025	DXCM DexCom	$0.33	$0.32	-$0.01	$0.27	$1.02 billion	$1.04 billion
4/30/2025	Q1 2025	ALGN Align Technology	$2.00	$2.13	+$0.13	$1.27	$977.90 million	$979.26 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
DXCM DexCom	N/A	N/A	N/A	N/A	N/A
HQY HealthEquity	N/A	N/A	N/A	N/A	N/A
HSIC Henry Schein	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.21	1.08
DXCM DexCom	0.55	1.50	1.32
HQY HealthEquity	0.50	4.06	4.06
HSIC Henry Schein	0.50	1.38	0.75

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
DXCM DexCom	97.75%
HQY HealthEquity	99.55%
HSIC Henry Schein	96.62%

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.66%
DXCM DexCom	0.32%
HQY HealthEquity	1.50%
HSIC Henry Schein	1.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	20,945	72.49 million	72.01 million	Optionable
DXCM DexCom	10,300	392.11 million	390.85 million	Optionable
HQY HealthEquity	3,120	86.47 million	85.18 million	Optionable
HSIC Henry Schein	25,000	121.72 million	120.41 million	Optionable

ALGN, DXCM, HQY, and HSIC Headlines

Recent News About These Companies

Palisade Capital Management LP Purchases 6,304 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

July 4 at 6:25 AM | marketbeat.com

Head-To-Head Comparison: Henry Schein (HSIC) & Its Rivals

July 4 at 2:01 AM | americanbankingnews.com

KBC Group NV Decreases Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

July 2 at 4:54 AM | marketbeat.com

Asset Management One Co. Ltd. Reduces Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

July 1 at 3:48 AM | marketbeat.com

Henry Schein (HSIC) is a Top-Ranked Value Stock: Should You Buy?

June 30, 2025 | zacks.com

Henry Schein, Inc. (HSIC) - Yahoo Finance

June 29, 2025 | finance.yahoo.com

K.J. Harrison & Partners Inc Sells 9,000 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

June 29, 2025 | marketbeat.com

Illinois Municipal Retirement Fund Sells 20,914 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

June 29, 2025 | marketbeat.com

Marathon Asset Management Ltd Sells 25,247 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

June 28, 2025 | marketbeat.com

Is Henry Schein Stock Outperforming the Dow?

June 27, 2025 | finance.yahoo.com

Canvas Wealth Advisors LLC Cuts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

June 27, 2025 | marketbeat.com

The Top 5 Analyst Questions From Henry Schein’s Q1 Earnings Call

June 27, 2025 | msn.com

Leerink Partners Keeps a Hold Rating on Henry Schein (HSIC) With a $69 PT

June 26, 2025 | msn.com

Is Henry Schein Stock Outperforming the Dow?

June 26, 2025 | msn.com

Henry Schein (HSIC) is a Top-Ranked Growth Stock: Should You Buy?

June 26, 2025 | zacks.com

Moran Wealth Management LLC Makes New Investment in Henry Schein, Inc. (NASDAQ:HSIC)

June 26, 2025 | marketbeat.com

3 Reasons to Avoid HSIC and 1 Stock to Buy Instead

June 24, 2025 | msn.com

Envestnet Portfolio Solutions Inc. Has $4.29 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

June 22, 2025 | marketbeat.com

Assenagon Asset Management S.A. Has $1.16 Million Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

June 18, 2025 | marketbeat.com

Dental Equipment & Technology Stocks Q1 Highlights: Henry Schein (NASDAQ:HSIC)

June 12, 2025 | finance.yahoo.com

Here's Why Henry Schein (HSIC) is a Strong Value Stock

June 12, 2025 | zacks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ALGN, DXCM, HQY, and HSIC Company Descriptions

Align Technology NASDAQ:ALGN

$196.92 -0.06 (-0.03%)

Closing price 07/3/2025 03:57 PM Eastern

Extended Trading

$196.92 -0.01 (0.00%)

As of 07/3/2025 04:31 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

DexCom NASDAQ:DXCM

$82.73 -0.85 (-1.02%)

Closing price 07/3/2025 03:57 PM Eastern

Extended Trading

$82.87 +0.14 (+0.17%)

As of 07/3/2025 04:38 PM Eastern

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

HealthEquity NASDAQ:HQY

$99.55 -1.73 (-1.71%)

Closing price 07/3/2025 03:44 PM Eastern

Extended Trading

$100.64 +1.10 (+1.10%)

As of 07/3/2025 04:53 PM Eastern

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Henry Schein NASDAQ:HSIC

$74.67 +0.19 (+0.25%)

Closing price 07/3/2025 03:25 PM Eastern

Extended Trading

$74.61 -0.05 (-0.07%)

As of 07/3/2025 04:20 PM Eastern

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time